This review presents information related to the opioid crisis in Australia and the initiatives taken by the Government in response. It also examines recent data, including post-marketing data, related to misuse, respiratory depression, mortality and serotonin syndrome for opioid pain medications.
It includes guiding commentary from Dr. Malcolm Hogg, a specialist in Anaesthesia and Pain Medicine, Royal Melbourne Hospital.
Please login below to download this issue (PDF)